Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

2.13
Delayed Data
As of 2:01pm ET
 -0.04 / -1.84%
Today’s Change
1.62
Today|||52-Week Range
4.27
-20.52%
Year-to-Date
Institutional investors purchased a net $68.7 thousand shares of GENE during the quarter ended December 2015 and now own 3.20% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2016SIMPLEX TRADING LLC  Sold 12.00 shares of Genetic Technologies Ltd
6/30/2016CREATIVE PLANNING, INC.  Sold 500.00 shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC2.75%314,380657,054-3,100-0.98%
Citadel Advisors LLC0.14%16,35534,182+16,355--
KCG Americas LLC0.12%13,78128,802+13,781--
RBC Capital Markets LLC (Investme...0.07%8,50017,765+8,500--
Morgan Stanley & Co. LLC0.05%5,48111,455-9,460-63.32%
Deutsche Asset Management Investm...0.03%3,0466,366+3,046--
KMS Financial Services, Inc.0.02%2,7505,74800.00%
Morgan Stanley Smith Barney LLC (...0.01%1,0002,090-1,750-63.64%
Jane Street Capital LLC0.00%00-19,449-100.00%
Simplex Trading LLC0.00%00-12-100.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change